BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

6 Months Ended

Jun. 30, 2016

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three and six months ended June 30, 2016 and 2015 are as follows:

	Three Months Ended								Six Months Ended
	June 30,								June 30,
	2016				2015				2016				2015
Laser systems		70.7	%			65.6	%			67.0	%			65.1	%
Imaging systems		5.0	%			4.5	%			5.6	%			3.8	%
Consumables and other		12.5	%			15.9	%			14.1	%			16.7	%
Services		11.4	%			13.7	%			13.0	%			13.8	%
License fees and royalties		0.4	%			0.3	%			0.3	%			0.6	%
Total revenue		100.0	%			100.0	%			100.0	%			100.0	%